Laminin gamma2-chain fragment in the circulation: a prognostic indicator of epithelial tumor invasion.
Laminin (LN) 5, the major component of epithelial-derived extracellular matrix (ECM), plays a major role in cell adhesion and motility. Previous reports stated that proteolytic processing of the NH(2)-terminal region of the gamma2 chain enhances cell motility on LN5, indicating that the degraded gamma2 chain NH(2)-terminal region would be shed from the ECM. However, soluble LN gamma2 NH(2)-terminal fragment (G2F) have not been detected in biological fluids. Here, we developed a double-monoclonal electrochemiluminescence immunoassay for human G2F and detected its presence in the normal human circulation (mean +/- SD: 39.2 +/- 10.3 ng/ml; n = 10). We also measured serum levels of G2F in nude mice orthotopically transplanted with three different human pancreatic carcinoma cell lines: MIApaca-II (secreting no LN5), HPAC (secreting the alpha3beta3gamma2 heterotrimer of LN5), or KP-1 (secreting the monomeric gamma2 chain of LN5). Serum levels of G2F drastically increased in the nude mice transplanted with HPAC (mean +/- SD: 351 +/- 33 ng/ml, 5 weeks after transplantation), the most invasive tumor cells to generate extensive peritoneal dissemination in vivo. A moderate increase in serum levels of G2F was also observed in mice transplanted with KP-1 (87.9 +/- 82 ng/ml, 5 weeks after transplantation), but no antigen was detected in the sera of MIApaca-II-transplanted mice. Therefore, circulating G2F was demonstrated to be a sensitive marker for LN5 production of primary pancreatic carcinomas, even if it was produced only as a monomeric gamma2 chain. In 11 established human pancreatic tumor cell lines (6 of LN5-producing cells and 5 of nonproducing cells), LN5-secreting cells have significantly higher levels of cell surface expression of beta4 integrin than nonsecreting cells. Thus, LN5 secretion is accompanied by cell surface expression of alpha6beta4 integrin, participating in hemidesmosome reorganization to form invading edges of malignant epithelial carcinomas. These data reveal that the level of circulating G2F is a new, prognostic, tumor-characterizing marker for estimating the invasiveness and malignancy of epithelial carcinomas in cancer patients.
Katayama
Masahiko
M
Diagnostic Department, Tsukuba Research Laboratories, Eisai Co., Ltd., Tsukuba, Ibaraki 300-2635, Japan. ml-katayama@eisai.co.jp
Sanzen
Noriko
N
Funakoshi
Akihiro
A
Sekiguchi
Kiyotoshi
K
D000230:Adenocarcinoma / Q000097:blood / Q000175:diagnosis; D000818:Animals; D014408:Biomarkers, Tumor / Q000097:blood; D002465:Cell Movement / Q000502:physiology; D005354:Fibrosarcoma / Q000097:blood / Q000175:diagnosis; D005909:Glioblastoma / Q000097:blood / Q000175:diagnosis; D006801:Humans; D007797:Laminin / Q000097:blood*; D051379:Mice; D008819:Mice, Nude; D009361:Neoplasm Invasiveness; D010190:Pancreatic Neoplasms / Q000097:blood / Q000175:diagnosis; D010446:Peptide Fragments / Q000097:blood*; D011379:Prognosis; D014183:Transplantation, Heterologous
D014408:Biomarkers, Tumor; C400567:LAMC2 protein, human; C498522:Lamc2 protein, mouse; D007797:Laminin; D010446:Peptide Fragments